Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I read that a few hours ago. Has a listed price value of like 6.70$ a share...interesting
Nice thanks Bl
sell 90 % keep 10 % that is what iam doing made a killing on RIMM still have more of both cash in 2012 before 2013..imo bl
Hey Bl
Been holding knight Capitol since 2.65 sitting on a nice profit but thinking of holding out with new merger. Any thoughts?
BRGO par value .001 looking to add at that PPS..has potential,imo
company has been selling...reason for recent drop
EPGL new highs hit again today@.009 --->>>last .008
Gsag unusual volume last week. Huge gaps low float great flip
acdu take a look...
Nice job BL! :)
selling my rimm that i bought at $8.00 at $13.90 today making $5.90 each share ...hit the gold mine here...leaving only 5% of rimm for the future ...made a ton...bl
GDSI nice volume-->> .08-.12 last few trading sessions
EPGL new highs hit today.. .008--->>> pennies in 2013
iam selling more rimm today from my buys at 7.50 making $5.00 each share...bl
A fool with money
Thursday, November 29, 2012 1:13:42 PM
Post # of 89736
Its time again preparing the bombers now.More then meets the
eye here.
Lots going on behind the curtain.
If you seek you will find.
Its Christmas time once again.
Dont look the gambling way.
Look at RE and shale
Its there
MERRY CHRISTMAS ONE AND ALL
IT WILL BE A VERY VERY HAPPY NEW YEAR
Edwy edwy edwy
Promo coming monday! Tiny 23m share float heavy accum and a great all around company! Big run coming get em while you can!!
i bought at 7 also
Before run to 11?? Wierd things going on in the stoc world this week with big runs
Gmcr
Yum
also sold my postion at the 7.00 range on rimm
Hope u bought more knight capitol bl makin a killing!!
MWWC you may want to look for dip, should of posted this ticker here at .0007 the other day. +66% on 3m- volume already today
Last .0014x.0015
happy bird day to all....bl
looking at norkia @$3.30
GDSI tanking on bid wacks .029 may want to look for cheapies if interested in it.
EPGL next week has a few things coming
1.) More OTC updates
2.) NAtional press release
3.) Q&A session via twitter live
EPGL financials out AH today, look good!
Nice $$$$$ BL... EPGL going to heat up. .0062 52week high today. Next leg coming key break coming in the next day or two, imo
First OTC update in 2 years coming tomorrow.
Friday, September 21, 2012 3:25:24 PM
Re: $BL$ post# 2434
Post # of 2463
LOVE RIMMM AT $6.50 EACH SOMEONE WILL BUY THEM OUT SOON !!!! BUYING BUYING BUYING
rimm @ $9.50 selling my position from the $6.00 range big $$$$$$$$$$$$$$$
EPGL - still long term buy, expecting financials very soon, then tier uplisting, .004 range is good entry, jmo
BRGO going to make moves from .003 time to buy is now, jmo
Pump coming in gstv tomorrow could get interesting!! In and out boys!
blueberry fields comes from= usa-sunnyvale,ca-Inktomi Corporation
BL...hope family and friends are safe out there on the east
Ambs
Biotech, 100m float, could be a good flip
Saw thr sideways trading for last cpl days. Any other good day trades? Somethin i can short, cover, than flip for a nice profit? Lol
sold bcrx this morning no gain no loss
also two weeks ago i bought SAND
http://www.sandstormmetalsandenergy.com.
Be careful holding long i know how pharma stocks work. Lot of good ones out there but tricky to trade. Gl. I like star scientific stsi and compugen cgen. Solid structures and usually some really nice swings
Zavoico follows BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) (Zavoico: Buy; Target $9), and out of curiosity I wanted to know about a preclinical compound, which is not something investors usually have much interest in because they rarely add value to shares. This case could be different. The compound is BCX5191 for hepatitis C (HCV), which is a nucleoside, not a nucleotide. “The fact that BCX5191 is a nucleoside could be an important advantage,” says Zavoico. “It is not a prodrug (an inactive chemical that is subsequently activated in the body by normal metabolic processes), as are the nucleotides, and it has shown high potency, as well as no notable toxicity, in preclinical studies.” BioCryst says that a phase 1 trial is expected to start before year end. “It is a new approach in this space,” he says. “But as far as monetizing this asset, I think it is too early right now.” True, the main value driver for the company today is its phase 2, ready for phase 3, compound ulodesine, a purine nucleoside phosphorylase (PNP) inhibitor, which is being studied in gout. “We expect BioCryst to announce a partnership deal for this asset long before it does so with BCX5191,” he says.
About BioCryst
BioCryst Pharmaceuticals designs, optimizes and develops novel small molecule drugs that block key enzymes involved in infectious and inflammatory diseases. BioCryst currently has two late-stage development programs: peramivir, a viral neuraminidase inhibitor for the treatment of influenza, and ulodesine (BCX4208), a purine nucleoside phosphorylase (PNP) inhibitor for the treatment of gout. In addition, BioCryst is advancing two preclinical programs towards IND filings: BCX5191, a nucleoside analog inhibitor of HCV RNA polymerase (NS5B) for hepatitis C, and BCX4161, an oral inhibitor of plasma kallikrein for hereditary angioedema. Utilizing state-of-the-art structure-guided drug design and crystallography, BioCryst continues to discover innovative compounds with the goal of addressing unmet medical needs of patients and physicians. For more information, please visit the Company's website at www.BioCryst.com.
Yepp red the 10q
Followers
|
10
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2552
|
Created
|
04/21/10
|
Type
|
Premium
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |